CIK 0000707388
STRR STAR EQUITY HOLDINGS, INC.
Insider trading from SEC Form 4. Last filing Aug 22, 2025. Close $10.32 on Oct 9, 2026, +12% from the 52-week low and -13% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Price and insider trades, last year
STRROct 9, 2026 · close 10.32
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at STAR EQUITY HOLDINGS, INC., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 76 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | Hannah M. Bible Chief Legal Officer | DDisposition to issuer Common Stock | -2,984 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Louis A. Parks director | DDisposition to issuer Common Stockindirect: By Contributory IRA | -1,200 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Thatcher Butcher President - KBS | DDisposition to issuer Common Stock | -7,345 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Jennifer Palmer director | DDisposition to issuer Restricted Stock Unitderivative | -1,570 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Richard Kenneth Coleman Jr. Chief Executive Officer | DDisposition to issuer Common Stock | -44,233 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | David J. Noble Chief Financial Officer | DDisposition to issuer Common Stock | -28,466 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Todd Michael Fruhbeis director | DDisposition to issuer Common Stock | -3,303 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Jeffrey E. Eberwein Executive Chairman | DDisposition to issuer Common Stock | -820,374 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Todd Michael Fruhbeis director | DDisposition to issuer 10% Series A Cumulative Perpetual Preferred Stock | -4,576 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Louis A. Parks director | DDisposition to issuer Restricted Stock Unitderivative | -1,655 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Jennifer Palmer director | DDisposition to issuer Restricted Stock Unitderivative | -1,723 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | David J. Noble Chief Financial Officer | DDisposition to issuer Restricted Stock Unitderivative | -3,413 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Jeffrey E. Eberwein Executive Chairman | DDisposition to issuer 10% Series A Cumulative Perpetual Preferred Stock | -1,182,414 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Hannah M. Bible Chief Legal Officer | DDisposition to issuer Restricted Stock Unitderivative | -1,638 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Thatcher Butcher President - KBS | DDisposition to issuer Restricted Stock Unitderivative | -1,714 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Richard Kenneth Coleman Jr. Chief Executive Officer | DDisposition to issuer 10% Series A Cumulative Perpetual Preferred Stock | -2,500 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | David J. Noble Chief Financial Officer | DDisposition to issuer Restricted Stock Unitderivative | -15,843 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Louis A. Parks director | DDisposition to issuer Restricted Stock Unitderivative | -1,816 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Hannah M. Bible Chief Legal Officer | DDisposition to issuer Restricted Stock Unitderivative | -6,435 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Jennifer Palmer director | DDisposition to issuer Restricted Stock Unitderivative | -460 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Thatcher Butcher President - KBS | DDisposition to issuer Restricted Stock Unitderivative | -3,187 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Richard Kenneth Coleman Jr. Chief Executive Officer | DDisposition to issuer Restricted Stock Unitderivative | -5,051 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Jeffrey E. Eberwein Executive Chairman | DDisposition to issuer Restricted Stock Unitderivative | -2,935 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Todd Michael Fruhbeis director | DDisposition to issuer Restricted Stock Unitderivative | -1,485 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Todd Michael Fruhbeis director | DDisposition to issuer Restricted Stock Unitderivative | -2,004 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | David J. Noble Chief Financial Officer | DDisposition to issuer Restricted Stock Unitderivative | -10,140 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Richard Kenneth Coleman Jr. Chief Executive Officer | DDisposition to issuer Restricted Stock Unitderivative | -19,499 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Jennifer Palmer director | DDisposition to issuer Restricted Stock Unitderivative | -460 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Hannah M. Bible Chief Legal Officer | DDisposition to issuer Restricted Stock Unitderivative | -4,071 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Jeffrey E. Eberwein Executive Chairman | DDisposition to issuer Restricted Stock Unitderivative | -3,221 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Louis A. Parks director | DDisposition to issuer Restricted Stock Unitderivative | -485 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Richard Kenneth Coleman Jr. Chief Executive Officer | DDisposition to issuer Restricted Stock Unitderivative | -12,813 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Louis A. Parks director | DDisposition to issuer Restricted Stock Unitderivative | -485 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Todd Michael Fruhbeis director | DDisposition to issuer Restricted Stock Unitderivative | -535 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Jeffrey E. Eberwein Executive Chairman | DDisposition to issuer Restricted Stock Unitderivative | -860 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Jeffrey E. Eberwein Executive Chairman | DDisposition to issuer Restricted Stock Unitderivative | -860 | - | - | 0 | Aug 22, 2025 |
| Aug 22, 2025 | Todd Michael Fruhbeis director | DDisposition to issuer Restricted Stock Unitderivative | -535 | - | - | 0 | Aug 22, 2025 |
| Aug 18, 2025 | Todd Michael Fruhbeis director | AGrant or award Restricted Stock Unitderivative | +535 | - | - | 535 | Aug 18, 2025 |
| Aug 18, 2025 | Louis A. Parks director | AGrant or award Restricted Stock Unitderivative | +485 | - | - | 485 | Aug 18, 2025 |
| Aug 18, 2025 | Jeffrey E. Eberwein Executive Chairman | AGrant or award Restricted Stock Unitderivative | +860 | - | - | 860 | Aug 18, 2025 |
| Aug 18, 2025 | Jennifer Palmer director | AGrant or award Restricted Stock Unitderivative | +460 | - | - | 460 | Aug 18, 2025 |
| Jul 27, 2025 | Hannah M. Bible Chief Legal Officer | MOption exercise Common Stock | +1,638 | - | - | 3,580 | Jul 28, 2025 |
| Jul 27, 2025 | Richard Kenneth Coleman Jr. Chief Executive Officer | MOption exercise Common Stock | +5,051 | - | - | 44,233 | Jul 28, 2025 |
| Jul 27, 2025 | David J. Noble Chief Financial Officer | MOption exercise Common Stock | +3,413 | - | - | 29,568 | Jul 28, 2025 |
| Jul 27, 2025 | Hannah M. Bible Chief Legal Officer | FTax withholding Common Stock | -596 | $2.10 | $1,252 | 2,984 | Jul 28, 2025 |
| Jul 27, 2025 | Richard Kenneth Coleman Jr. Chief Executive Officer | MOption exercise Restricted Stock Unitderivative | -5,051 | - | - | 5,051 | Jul 28, 2025 |
| Jul 27, 2025 | David J. Noble Chief Financial Officer | FTax withholding Common Stock | -1,102 | $2.10 | $2,314 | 28,466 | Jul 28, 2025 |
| Jul 27, 2025 | Hannah M. Bible Chief Legal Officer | MOption exercise Restricted Stock Unitderivative | -1,638 | - | - | 1,638 | Jul 28, 2025 |
| Jul 27, 2025 | David J. Noble Chief Financial Officer | MOption exercise Restricted Stock Unitderivative | -3,413 | - | - | 3,413 | Jul 28, 2025 |
| May 23, 2025 | Jeffrey E. Eberwein Executive Chairman | MOption exercise Common Stock | +1,912 | - | - | 820,374 | May 27, 2025 |
| May 23, 2025 | Jeffrey E. Eberwein Executive Chairman | MOption exercise Restricted Stock Unitderivative | -1,912 | - | - | 0 | May 27, 2025 |
| May 19, 2025 | Jeffrey E. Eberwein Executive Chairman | AGrant or award Restricted Stock Unitderivative | +860 | - | - | 860 | May 21, 2025 |
| May 19, 2025 | Todd Michael Fruhbeis director | AGrant or award Restricted Stock Unitderivative | +535 | - | - | 535 | May 21, 2025 |
| May 19, 2025 | Jennifer Palmer director | AGrant or award Restricted Stock Unitderivative | +460 | - | - | 460 | May 21, 2025 |
| May 19, 2025 | Louis A. Parks director | AGrant or award Restricted Stock Unitderivative | +485 | - | - | 485 | May 21, 2025 |
| Mar 27, 2025 | Jeffrey E. Eberwein Executive Chairman | MOption exercise Common Stock | +1,914 | - | - | 818,462 | Mar 27, 2025 |
| Mar 27, 2025 | Jeffrey E. Eberwein Executive Chairman | MOption exercise Restricted Stock Unitderivative | -1,914 | - | - | 0 | Mar 27, 2025 |
| Mar 25, 2025 | Hannah M. Bible Chief Legal Officer | AGrant or award Restricted Stock Unitderivative | +4,071 | - | - | 4,071 | Mar 26, 2025 |
| Mar 25, 2025 | Todd Michael Fruhbeis director | AGrant or award Restricted Stock Unitderivative | +2,004 | - | - | 2,004 | Mar 26, 2025 |
| Mar 25, 2025 | Richard Kenneth Coleman Jr. Chief Executive Officer | AGrant or award Restricted Stock Unitderivative | +12,813 | - | - | 12,813 | Mar 26, 2025 |
| Mar 25, 2025 | Jeffrey E. Eberwein Executive Chairman | AGrant or award Restricted Stock Unitderivative | +3,221 | - | - | 3,221 | Mar 26, 2025 |
| Mar 13, 2025 | Thatcher Butcher President - KBS | MOption exercise Common Stock | +1,594 | - | - | 7,345 | Mar 14, 2025 |
| Mar 13, 2025 | Thatcher Butcher President - KBS | MOption exercise Restricted Stock Unitderivative | -1,594 | - | - | 3,187 | Mar 14, 2025 |
| Mar 3, 2025 | Thatcher Butcher President - KBS | MOption exercise Common Stock | +1,715 | - | - | 3,430 | Mar 3, 2025 |
| Mar 3, 2025 | Thatcher Butcher President - KBS | MOption exercise Restricted Stock Unitderivative | -1,715 | - | - | 1,714 | Mar 3, 2025 |
| Jan 1, 2025 | Richard Kenneth Coleman Jr. Chief Executive Officer | MOption exercise Common Stock | +2,615 | - | - | 39,182 | Jan 2, 2025 |
| Jan 1, 2025 | Richard Kenneth Coleman Jr. Chief Executive Officer | MOption exercise Restricted Stock Unitderivative | -2,615 | - | - | 0 | Jan 2, 2025 |
| Nov 22, 2024 | Jeffrey E. Eberwein Executive Chairman | AGrant or award Restricted Stock Unitderivative | +2,935 | - | - | 2,935 | Nov 26, 2024 |
| Nov 22, 2024 | Louis A. Parks director | AGrant or award Restricted Stock Unitderivative | +1,655 | - | - | 1,655 | Nov 26, 2024 |
| Nov 22, 2024 | Jennifer Palmer director | AGrant or award Restricted Stock Unitderivative | +1,570 | - | - | 1,570 | Nov 26, 2024 |
| Nov 22, 2024 | Todd Michael Fruhbeis director | AGrant or award Restricted Stock Unitderivative | +1,485 | - | - | 1,485 | Nov 26, 2024 |
| Nov 13, 2024 | Jeffrey E. Eberwein Executive Chairman | MOption exercise Common Stock | +1,978 | - | - | 816,548 | Nov 14, 2024 |
| Nov 13, 2024 | Jeffrey E. Eberwein Executive Chairman | MOption exercise Restricted Stock Unitderivative | -1,978 | - | - | 0 | Nov 14, 2024 |
| Nov 8, 2024 | Hannah M. Bible Chief Legal Officer | AGrant or award Restricted Stock Unitderivative | +6,435 | - | - | 6,435 | Nov 13, 2024 |
| Nov 8, 2024 | Richard Kenneth Coleman Jr. Chief Executive Officer | AGrant or award Restricted Stock Unitderivative | +19,499 | - | - | 19,499 | Nov 13, 2024 |
| Nov 8, 2024 | David J. Noble Chief Financial Officer | AGrant or award Restricted Stock Unitderivative | +15,843 | - | - | 15,843 | Nov 13, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Hannah M. BibleChief Legal Officer
- Thatcher ButcherPresident - KBS
- Richard Kenneth Coleman Jr.Chief Executive Officer
- Jeffrey E. EberweinExecutive Chairman
- Todd Michael Fruhbeisdirector
- David J. NobleChief Financial Officer
- Jennifer Palmerdirector
- Louis A. Parksdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.